StemGen Inc. (SGNI) Financials Oct 28, 2014, 12:00
Post# of 250675
Posted On: 11/17/2014 3:43:26 AM
StemGen Inc. (SGNI) Financials Oct 28, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for StemGen Inc.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 0 0 0
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income 0 0 0 0 0
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 37,726 41,946 27,710 60,202 51,183
Research & Development 0 0 0 0 -
Other SG&A 37,726 41,946 27,710 60,202 51,183
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 (32,500) (107,220)
EBIT after Unusual Expense 0 0 0 32,500 107,220
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 17,475 17,098 40,660 60,717 39,617
Gross Interest Expense 17,475 17,098 40,660 60,717 39,617
Interest Capitalized 0 0 0 0 0
Pretax Income (55,201) (59,044) (68,370) (88,419) 16,420
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (55,201) (59,044) (68,370) (88,419) 16,420
Minority Interest Expense 0 0 0 0 0
Net Income (55,201) (59,044) (68,370) (88,419) 16,420
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (55,201) (59,044) (68,370) (88,419) 16,420
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (55,201) (59,044) (68,370) (88,419) 16,420
EPS (Basic) (0.80) (0.80) (0.80) (0.49) 0.01
Basic Shares Outstanding 83,365 108,708 168,343 182,253 1.31M
EPS (Diluted) (0.80) (0.80) (0.80) (0.49) 0.01
Diluted Shares Outstanding 83,365 108,708 168,343 182,253 1.31M
EBITDA (37,726) (41,946) (27,710) (60,202) (51,183)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for StemGen Inc.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 0 0 0
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income 0 0 0 0 0
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 37,726 41,946 27,710 60,202 51,183
Research & Development 0 0 0 0 -
Other SG&A 37,726 41,946 27,710 60,202 51,183
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 (32,500) (107,220)
EBIT after Unusual Expense 0 0 0 32,500 107,220
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 17,475 17,098 40,660 60,717 39,617
Gross Interest Expense 17,475 17,098 40,660 60,717 39,617
Interest Capitalized 0 0 0 0 0
Pretax Income (55,201) (59,044) (68,370) (88,419) 16,420
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (55,201) (59,044) (68,370) (88,419) 16,420
Minority Interest Expense 0 0 0 0 0
Net Income (55,201) (59,044) (68,370) (88,419) 16,420
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (55,201) (59,044) (68,370) (88,419) 16,420
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (55,201) (59,044) (68,370) (88,419) 16,420
EPS (Basic) (0.80) (0.80) (0.80) (0.49) 0.01
Basic Shares Outstanding 83,365 108,708 168,343 182,253 1.31M
EPS (Diluted) (0.80) (0.80) (0.80) (0.49) 0.01
Diluted Shares Outstanding 83,365 108,708 168,343 182,253 1.31M
EBITDA (37,726) (41,946) (27,710) (60,202) (51,183)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)